← All organizations
Highest phase reached
Phase 4
First clinical trial
Jul 1, 2011Last known activity
May 21, 2025
Timeline
1980s
- Jan 1, 1984
Jilin Provincial Tumor Hospital— Founded
Drugs by trial phase (59 distinct, 43 trials)
Phase 4 (3 own, 0 via acquisition)
Phase 3 (28 own, 0 via acquisition)
Phase 2 (17 own, 0 via acquisition)
Indications
Studied for
- Breast Neoplasms
- Carcinoma
- Carcinoma, Hepatocellular
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Colorectal Neoplasms
- Lung Neoplasms
- Multiple Myeloma
- Nasopharyngeal Carcinoma
- Neoplasms
- Neoplasms, Plasma Cell
- Ovarian Neoplasms
- Rectal Neoplasms
- Small Cell Lung Carcinoma
- Stomach Neoplasms
- Uterine Cervical Neoplasms
Recent trials (46)
- NCT06685653CollaboratorEarly Phase 1—
- NCT06902350OfficialPhase 1May 21, 2025
- NCT06936735OfficialPhase 1Apr 17, 2025
- NCT06616532OfficialPhase 3Oct 25, 2024
- NCT06496048OfficialPhase 3Aug 31, 2024
- NCT06426056CollaboratorPhase 2Jun 30, 2024
- NCT05924841Overall official - principal investigatorPhase 2Nov 10, 2023
- NCT06247605OfficialPhase 3Oct 26, 2023
- NCT06020066OfficialPhase 2Aug 10, 2023
- NCT06020066Overall official - principal investigatorPhase 2Aug 10, 2023
- NCT05844150Overall official - principal investigatorPhase 2/Phase 3Jun 30, 2023
- NCT05863325Overall official - principal investigatorPhase 2Jun 27, 2023
- NCT05955391CollaboratorPhase 2Jan 18, 2023
- NCT05879068Overall official - principal investigatorPhase 2May 27, 2022
- NCT05353257OfficialPhase 3May 17, 2022
Details
- Founded
- Changchun, CN Jan 1, 1984
- Last known activity
- May 21, 2025